Initiating activity of 4-chlorobiphenyl metabolites in the resistant hepatocyte model.
D015073:2-Acetylaminofluorene / Q000008:administration & dosage; D018248:Adenoma, Liver Cell / Q000139:chemically induced; D000284:Administration, Oral; D000818:Animals; D001713:Biphenyl Compounds / Q000009:adverse effects* / Q000737:chemistry / Q000378:metabolism*; D001835:Body Weight / Q000187:drug effects; D002251:Carbon Tetrachloride / Q000008:administration & dosage; D002273:Carcinogens / Q000009:adverse effects / Q000737:chemistry / Q000378:metabolism; D004052:Diethylnitrosamine / Q000008:administration & dosage / Q000009:adverse effects; D004334:Drug Administration Schedule; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006900:Hydroxylation; D007274:Injections, Intraperitoneal; D007442:Intubation, Intratracheal; D008099:Liver / Q000737:chemistry / Q000187:drug effects / Q000473:pathology; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced* / Q000517:prevention & control*; D008297:Male; D008954:Models, Biological; D009929:Organ Size / Q000187:drug effects; D011809:Quinones / Q000009:adverse effects / Q000737:chemistry / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D013997:Time Factors; D005723:gamma-Glutamyltransferase / Q000096:biosynthesis / Q000737:chemistry
D001713:Biphenyl Compounds; D002273:Carcinogens; D011809:Quinones; D004052:Diethylnitrosamine; D015073:2-Acetylaminofluorene; D002251:Carbon Tetrachloride; D005723:gamma-Glutamyltransferase; C006983:4-chlorobiphenyl